Electro-Optical Sciences Announces Participation at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

IRVINGTON, NY--(Marketwire - May 29, 2008) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind®, a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma, today announced that Joseph V. Gulfo, MD, MBA, president and chief executive officer, will present at the Needham & Company Biotechnology and Medical Technology Conference taking place at The New York Palace Hotel, June 11 - 12, 2008.

Dr. Gulfo's presentation is scheduled for Wednesday, June 11 at 1:30pm ET. To access the live webcast of this presentation visit www.eosciences.com. A replay of this presentation will be available on the company's website for thirty days following the presentation.

About Electro-Optical Sciences

Electro-Optical Sciences (EOS) is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to help physicians more effectively diagnose melanoma at an early stage. MelaFind®, the company's flagship product, incorporates advanced imaging technology and algorithms to provide physicians with unique data and an immediate recommendation of whether a suspicious lesion should be biopsied.

Melanoma is the deadliest of skin cancers, responsible for approximately 80% of all skin cancer deaths. Unless melanoma is detected early and excised with proper margins, the patient survival rate is poor, as there is currently no cure for advanced stage melanoma.

For more information on EOS, visit www.eosciences.com.

Safe Harbor

This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved. Actual results may differ materially from our beliefs or expectations due to economic, business, competitive, market and regulatory factors.

Contact Information: For further information contact: David Carey Lazar Partners Ltd. 212-867-1768